West Bancorporation’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Sell
17,975
-1,800
-9% -$47.1K 0.19% 59
2026
Q1
$555K Sell
19,775
-1,575
-7% -$41.9K 0.28% 50
2025
Q4
$532K Hold
21,350
0.28% 51
2025
Q3
$544K Hold
21,350
0.3% 50
2025
Q2
$518K Sell
21,350
-1,113
-5% -$26K 0.33% 49
2025
Q1
$569K Hold
22,463
0.39% 43
2024
Q4
$596K Hold
22,463
0.39% 42
2024
Q3
$650K Hold
22,463
0.43% 39
2024
Q2
$629K Sell
22,463
-2,291
-9% -$63.1K 0.47% 36
2024
Q1
$687K Sell
24,754
-1,675
-6% -$46.5K 0.45% 39
2023
Q4
$761K Sell
26,429
-468
-2% -$14.1K 0.49% 41
2023
Q3
$892K Sell
26,897
-286
-1% -$10.1K 0.63% 31
2023
Q2
$997K Buy
27,183
+1,689
+7% +$65.7K 0.67% 32
2023
Q1
$1.04M Sell
25,494
-1,200
-4% -$51.8K 0.79% 30
2022
Q4
$1.37M Sell
26,694
-4,242
-14% -$203K 1.02% 25
2022
Q3
$1.35M Sell
30,936
-948
-3% -$46.1K 1.01% 22
2022
Q2
$1.67M Buy
31,884
+3,097
+11% +$158K 1.18% 18
2022
Q1
$1.49M Buy
28,787
+12,541
+77% +$651K 0.92% 18
2021
Q4
$959K Buy
+16,246
New +$805K 0.75% 19
2020
Q3
$741K Hold
21,274
0.87% 20
2020
Q2
$660K Hold
21,274
0.77% 23
2020
Q1
$659K Hold
21,274
0.92% 20
2019
Q4
$791K Buy
+21,274
New +$758K 0.79% 21

Other funds holding PFE

West Bancorporation's PFE Position: Q2 2026 in Review

West Bancorporation reduced its Pfizer (PFE) stake by 9.1% in Q2 2026, selling an estimated $47.1K and leaving 17,975 shares worth $433K. The position accounts for 0.19% of the portfolio, ranked #59.

West Bancorporation first reported a position in PFE in Q4 2019 and has held it in 23 quarters since. The position peaked at $1.67M in Q2 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • West Bancorporation held 17,975 shares of Pfizer worth $433K as of Q2 2026.
  • West Bancorporation sold 1,800 Pfizer shares in Q2 2026, an estimated $47.1K.
  • Pfizer made up 0.19% of West Bancorporation's portfolio in Q2 2026, its #59 holding.
  • West Bancorporation first reported a position in Pfizer in Q4 2019 and has held it in 23 quarters since.
  • West Bancorporation's Pfizer position peaked at $1.67M in Q2 2022.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on West Bancorporation's 13F filing for Q2 2026, filed 23 Jul 2026.